Benzimidazole and imidazole inhibitors of histone deacetylases: Synthesis and biological activity

被引：47

作者：

Bressi, Jerome C. ^{[1
]}

de Jong, Ron ^{[1
]}

Wu, Yiqin ^{[1
]}

Jennings, Andy J. ^{[1
]}

Brown, Jason W. ^{[1
]}

O'Connell, Shawn ^{[1
]}

Tari, Leslie W. ^{[1
]}

Skene, Robert J. ^{[1
]}

Vu, Phong ^{[1
]}

Navre, Marc ^{[1
]}

Cao, Xiaodong ^{[1
]}

Gangloff, Anthony R. ^{[1
]}

机构：

[1] Takeda San Diego, San Diego, CA 92121 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 10期

关键词：

Histone deacetylase inhibitors; HDAC; Oncology;

D O I：

10.1016/j.bmcl.2010.03.092

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of N-hydroxy-3-[3-(1-substituted-1H-benzoimidazol-2-yl)-phenyl]-acrylamides (5a-5ab) and N-hydroxy-3-[ 3-( 1,4,5-trisubstituted-1H-imidazol-2-yl)-phenyl]-acrylamides (12a-s) were designed, synthesized, and found to be nanomolar inhibitors of human histone deacetylases. Multiple compounds bearing an N1-piperidine demonstrate EC(50)s of 20-100 nM in human A549, HL60, and PC3 cells, in vitro and in vivo hyperacetylation of histones H3 and H4, and induction of p21(waf). Compound 5x displays efficacy in human tumor xenograft models. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：3138 / 3141

页数：4

共 50 条

[21] The application of histone deacetylases inhibitors in glioblastoma
Rui Chen
Mengxian Zhang
Yangmei Zhou
Wenjing Guo
Ming Yi
Ziyan Zhang
Yanpeng Ding
Yali Wang
Journal of Experimental & Clinical Cancer Research, 39
[22] Histone deacetylases and their inhibitors in inflammatory diseases
Zhang, Sen-Yu
Zhang, Li-Ying
Wen, Ri
Yang, Ni
Zhang, Tie-Ning
BIOMEDICINE & PHARMACOTHERAPY, 2024, 179
[23] HISTONE DEACETYLASES: PROMOTERS AND INHIBITORS OF NEURODEGENERATION
D'Mello, S. R.
JOURNAL OF NEUROCHEMISTRY, 2011, 118 : 12 - 12
[24] Histone deacetylases and transcriptional therapy with their inhibitors
Pier Pandolfi
Cancer Chemotherapy and Pharmacology, 2001, 48 : S17 - S19
[25] Design and synthesis of novel pyrimidine hydroxamic acid inhibitors of histone deacetylases
Donald, Alastair D. G.
Clark, Vanessa L.
Patel, Sanjay
Day, Francesca A.
Rowlands, Martin G.
Wibata, Judata
Stimson, Lindsay
Hardcastle, Anthea
Eccles, Sue A.
McNamara, Deborah
Needham, Lindsey A.
Raynaud, Florence I.
Aherne, Wynne
Moffat, David F.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (22) : 6657 - 6660
[26] Synthesis and biological activity of splitomicin analogs targeted at human NAD+-dependent histone deacetylases (sirtuins)
Freitag, Marcus
Schemies, Joerg
Larsen, Tim
El Gaghlab, Khattab
Schulz, Felix
Rumpf, Tobias
Jung, Manfred
Link, Andreas
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (12) : 3669 - 3677
[27] IMIDAZOLE DERIVATIVES, SYNTHESIS AND BIOLOGICAL ACTIVITY
Abbasov, V. M.
Marzouk, Adel A.
Mammadov, A. M.
Kazimova, S. Z.
Talybov, A. H.
PROCESSES OF PETROCHEMISTRY AND OIL REFINING, 2012, 13 (04): : 347 - 364
[28] SYNTHESIS AND BIOLOGICAL ACTIVITY OF IMIDAZOLE DERIVATIVES
Wagh, S. S.
Patil, B. R.
Kasralikar, H. M.
HETEROCYCLIC LETTERS, 2020, 10 (03): : 491 - 508
[29] Synthesis, biological evaluation and molecular modeling studies of psammaplin A and its analogs as potent histone deacetylases inhibitors and cytotoxic agents
Wen, Jiachen
Bao, Yu
Niu, Qun
Liu, Jiang
Yang, Jinyu
Wang, Wanqiao
Jiang, Tao
Fan, Yinbo
Li, Kun
Wang, Jian
Zhao, Linxiang
Liu, Dan
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (17) : 232 - 236
[30] Synthesis and antimicrobial activity of substituted benzimidazole, benzothiazole and imidazole derivatives
Kucukbay, H
Cetinkaya, E
Durmaz, R
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1995, 45-2 (12): : 1331 - 1334

← 1 2 3 4 5 →